|
|
|
|
|
|
Collaboration and Licensing |
| |
|
| |
InSight seeks strategic partners and investors for the following technologies and
development programs:
• Co-development of Biosimilars
• Small-molecule anti-cancer NCE drugs
• Heparanase-detection ELISA
• Site-specific PEGylation
|
| |
|
|
|
